X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19116) 19116
Publication (1506) 1506
Newsletter (567) 567
Book Review (249) 249
Book Chapter (114) 114
Newspaper Article (56) 56
Conference Proceeding (30) 30
Magazine Article (17) 17
Dissertation (16) 16
Reference (8) 8
Book / eBook (5) 5
Transcript (4) 4
Data Set (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9985) 9985
animals (8880) 8880
male (8831) 8831
index medicus (7835) 7835
glucagon (6738) 6738
endocrinology & metabolism (5394) 5394
female (5307) 5307
glucagon-like peptide-1 (5198) 5198
insulin (4345) 4345
rats (4146) 4146
glucose (3982) 3982
insulin - blood (3700) 3700
adult (3598) 3598
blood glucose - metabolism (3559) 3559
diabetes (3418) 3418
glucagon - blood (3231) 3231
type 2 diabetes (2882) 2882
middle aged (2866) 2866
insulin - metabolism (2499) 2499
mice (2402) 2402
diabetes mellitus, type 2 - drug therapy (2397) 2397
glucagon - pharmacology (2073) 2073
insulin secretion (1830) 1830
research (1807) 1807
pharmacology & pharmacy (1787) 1787
obesity (1717) 1717
peptides (1713) 1713
glp-1 (1704) 1704
hypoglycemic agents - therapeutic use (1689) 1689
secretion (1669) 1669
glucagon - metabolism (1644) 1644
physiological aspects (1624) 1624
dextrose (1616) 1616
blood glucose - analysis (1615) 1615
glucagon-like peptide 1 (1604) 1604
aged (1474) 1474
diabetes mellitus (1448) 1448
physiology (1444) 1444
glucose - metabolism (1416) 1416
metabolism (1407) 1407
analysis (1384) 1384
liver - metabolism (1367) 1367
time factors (1335) 1335
insulin resistance (1302) 1302
glucagon - administration & dosage (1252) 1252
blood glucose - drug effects (1185) 1185
glucose metabolism (1142) 1142
hyperglycemia (1128) 1128
hypoglycemic agents - administration & dosage (1128) 1128
glucose tolerance test (1125) 1125
internal medicine (1121) 1121
medicine & public health (1112) 1112
glycemic control (1096) 1096
liraglutide (1090) 1090
diabetes mellitus, type 2 - blood (1067) 1067
dose-response relationship, drug (1056) 1056
biochemistry & molecular biology (1044) 1044
health aspects (1038) 1038
care and treatment (1032) 1032
food-intake (1030) 1030
dogs (1012) 1012
rodents (983) 983
rats, sprague-dawley (979) 979
hypoglycemic agents - pharmacology (962) 962
diabetes mellitus, type 2 - metabolism (948) 948
glucagon-like peptide 1 - metabolism (947) 947
abridged index medicus (918) 918
nutrition & dietetics (917) 917
hypoglycemia (901) 901
insulin - administration & dosage (896) 896
body weight (885) 885
diabetes therapy (881) 881
treatment outcome (864) 864
pancreas (861) 861
exenatide (849) 849
kinetics (844) 844
glucagon-like peptide-1 receptor (841) 841
insulin - pharmacology (836) 836
insulin-secretion (831) 831
digestive, oral, and skin physiology (820) 820
homeostasis (799) 799
rats, wistar (794) 794
fatty acids, nonesterified - blood (783) 783
glucagon-like peptide 1 - blood (783) 783
mice, inbred c57bl (783) 783
islets of langerhans - metabolism (779) 779
glucose - pharmacology (773) 773
hormones (770) 770
liver - drug effects (767) 767
glucagon-like peptide 1 - analogs & derivatives (760) 760
endocrine system (756) 756
article (755) 755
hypoglycemic agents (754) 754
drug therapy (748) 748
expression (747) 747
liver (744) 744
adolescent (743) 743
glucose - administration & dosage (741) 741
beta-cell function (740) 740
medicine, research & experimental (730) 730
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19191) 19191
German (149) 149
Japanese (126) 126
French (107) 107
Italian (60) 60
Russian (45) 45
Spanish (40) 40
Polish (32) 32
Czech (16) 16
Chinese (14) 14
Danish (9) 9
Portuguese (8) 8
Hungarian (7) 7
Korean (4) 4
Serbian (4) 4
Turkish (4) 4
Bulgarian (3) 3
Swedish (3) 3
Dutch (2) 2
Norwegian (2) 2
Slovak (2) 2
Afrikaans (1) 1
Arabic (1) 1
Bosnian (1) 1
Hebrew (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes Care, ISSN 0149-5992, 2014, Volume 37, Issue 8, pp. 2317 - 2325
Journal Article
Diabetes Care, ISSN 0149-5992, 2014, Volume 37, Issue 8, pp. 2159 - 2167
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 04/2017, Volume 19, Issue 4, pp. 524 - 536
Aims To compare efficacy and safety of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) in people with type 2 diabetes. Materials and methods We... 
GLP‐1 analogue | type 2 diabetes | network meta‐analysis | systematic review | network meta-analysis | GLP-1 analogue | GLYCEMIC CONTROL | EXENATIDE TWICE | ONCE-DAILY LIXISENATIDE | OPEN-LABEL | EUROPEAN ASSOCIATION | NETWORK METAANALYSIS | METFORMIN-TREATED PATIENTS | BASAL INSULIN | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | Glucagon-Like Peptide 1 - administration & dosage | Recombinant Fusion Proteins - adverse effects | Glucagon-Like Peptides - administration & dosage | Humans | Middle Aged | Glycated Hemoglobin A - drug effects | Male | Immunoglobulin Fc Fragments - administration & dosage | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Venoms - administration & dosage | Female | Hypoglycemia - chemically induced | Glucagon-Like Peptides - analogs & derivatives | Immunoglobulin Fc Fragments - adverse effects | Recombinant Fusion Proteins - administration & dosage | Drug Administration Schedule | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Treatment Outcome | Randomized Controlled Trials as Topic | Blood Glucose - drug effects | Glucagon-Like Peptides - adverse effects | Diabetes Mellitus, Type 2 - blood | Liraglutide - adverse effects | Incretins - adverse effects | Liraglutide - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Glucagon-Like Peptide-1 Receptor - agonists | Incretins - administration & dosage | Peptides - adverse effects | Type 2 diabetes | Glycosylated hemoglobin | Glucagon | Analysis | Diabetes therapy | Hypoglycemia | Diabetes
Journal Article
The Lancet, ISSN 0140-6736, 2006, Volume 368, Issue 9548, pp. 1696 - 1705
Glucagon-like peptide 1 (GLP-1) is a gut-derived incretin hormone that stimulates insulin and suppresses glucagon secretion, inhibits gastric emptying, and... 
MEDICINE, GENERAL & INTERNAL | IN-VITRO | METFORMIN-TREATED PATIENTS | HEALTHY-SUBJECTS | 2ND-PHASE INSULIN-SECRETION | IMPROVES GLYCEMIC CONTROL | BETA-CELL APOPTOSIS | IV INHIBITOR | 7-36 AMIDE | IMPROVED GLUCOSE-TOLERANCE | EXENATIDE SYNTHETIC EXENDIN-4 | Triazoles - administration & dosage | Triazoles - adverse effects | Glucagon-Like Peptide 1 - administration & dosage | Humans | Pyrazines - administration & dosage | Glucagon-Like Peptide 1 - biosynthesis | Dipeptidyl Peptidase 4 | Glucagon-Like Peptide 1 - physiology | Pyrazines - therapeutic use | Adenosine Deaminase Inhibitors | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Adamantane - therapeutic use | Pyrrolidines | Venoms - administration & dosage | Nitriles | Sitagliptin Phosphate | Adamantane - administration & dosage | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Glucagon-Like Peptide 1 - classification | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Drug Administration Schedule | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glycoproteins - antagonists & inhibitors | Clinical Trials as Topic | Glucagon-Like Peptide-1 Receptor | Dipeptidyl-Peptidase IV Inhibitors | Pyrazines - adverse effects | Venoms - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Care and treatment | Diagnosis | Glucagon | Analysis | Dosage and administration | Research | Protease inhibitors | Drug therapy | Proteins | Diabetes | Kinases | Insulin | Rodents
Journal Article
Advanced Drug Delivery Reviews, ISSN 0169-409X, 06/2013, Volume 65, Issue 6, pp. 782 - 799
Among 12 billion injections administered annually, unsafe delivery leads to > 20 million infections and > 100 million reactions. In an emerging new concept,... 
Molecular farming | Infectious diseases | Bioencapsulation | Hemophilia | Oral vaccines | Autoantigens | Diabetes | Lyophilization | TOXIN-B-SUBUNIT | APICAL MEMBRANE ANTIGEN-1 | HEAT-LABILE ENTEROTOXIN | ESCHERICHIA-COLI | MEROZOITE SURFACE PROTEIN-1 | YERSINIA-PESTIS | TRANSGENIC CHLOROPLASTS | FUSION PROTEIN | PHARMACOLOGY & PHARMACY | NASAL DRUG-DELIVERY | CHOLERA-TOXIN | Factor IX - administration & dosage | Proteins - pharmacokinetics | Administration, Oral | Humans | Vaccines - pharmacokinetics | Freeze Drying | Autoantigens - administration & dosage | Biological Availability | Blood Glucose | Plant Cells | Exenatide | Gastrointestinal Tract - metabolism | Peptides - administration & dosage | Drug Carriers | Plague Vaccine - administration & dosage | Diabetes Mellitus - prevention & control | Malaria Vaccines - administration & dosage | Diabetes Mellitus - therapy | Proteins - administration & dosage | Venoms - administration & dosage | Cholera Vaccines - administration & dosage | Proinsulin - administration & dosage | Vaccines - administration & dosage | Autoimmunity | Glucagon | Dendritic cells | Blood sugar | Biological products industry | Vaccines | Glutamate | Prothrombin complex concentrate | Biopharmaceutics | Proteins | Prevention | Glucose metabolism | Type 1 diabetes | Gastrointestinal system | Cholera toxin | Health aspects | Acids | hemophilia | lyophilization | molecular farming | infectious diseases | bioencapsulation | oral vaccines | diabetes
Journal Article
Diabetes Care, ISSN 0149-5992, 10/2014, Volume 37, Issue 10, pp. 2763 - 2773
Journal Article
Diabetes Care, ISSN 0149-5992, 2014, Volume 37, Issue 8, pp. 2149 - 2158
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 11/2015, Volume 17, Issue 11, pp. 1065 - 1074
Journal Article